跳至主要内容
临床试验/CTRI/2023/03/050680
CTRI/2023/03/050680尚未招募不适用

Human Papilloma Virus -Prevalence & Type Distribution Among Gynaecologists In Kerala State India

KFOG1 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2023年3月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
282
试验地点
1
主要终点
Detect the number of women with HPV virus on testing

研究概览

简要总结

Cervical cancer is the fourth most common cancer among women globally with an estimated 5,70,000 new cases in 2018. Nearly 90% of the 3,11000 deaths worldwide in 2018 occurred in low middle income countries. The global strategy towards eliminating cervical cancer as a public health problem adopted by WHO in 2020, recommends a comprehensive approach to cervical cancer prevention and control. The primary prevention is by HPV vaccination. Secondary prevention aims at screening women 30 years or older with a high performance test like HPV test followed by immediate treatment as quickly as possible. T o end cervical cancer 7/10 women should be screened by 35 years of age.

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • All married gynecologists in Kerala .

排除标准

  • Unmarried Pregnant Within 45 days after abortion Menstrual periods Known case of CA cervix Persons who had undergone Hysterectomy.

结局指标

主要结局

Detect the number of women with HPV virus on testing

时间窗: 2 weeks

次要结局

  • Genotype of the HPV virus in those women with positive test(2 weeks)

研究者

发起方
KFOG
申办方类型
Other [Federation of Obstetrics and Gynaecological Societies and clubs of kerala]

研究点 (1)

Loading locations...

相似试验